ES2694667T3 - Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato - Google Patents
Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato Download PDFInfo
- Publication number
- ES2694667T3 ES2694667T3 ES14819001.0T ES14819001T ES2694667T3 ES 2694667 T3 ES2694667 T3 ES 2694667T3 ES 14819001 T ES14819001 T ES 14819001T ES 2694667 T3 ES2694667 T3 ES 2694667T3
- Authority
- ES
- Spain
- Prior art keywords
- oxalate
- oxidases
- recombinant
- treatment
- related diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
- C12Y102/03004—Oxalate oxidase (1.2.3.4)
Abstract
Oxalato oxidasa recombinante que tiene una identidad de secuencia de al menos el 60% con los polipéptidos de SEQ ID NO: 2, SEQ ID NO: 4 o SEQ ID NO: 6, o una identidad de secuencia de al menos el 99% con el polipéptido de SEQ ID NO: 8, y en la que la oxalato oxidasa recombinante puede degradar oxalato con una actividad relativa de al menos el 20% a pH 7,5, en la que se calcula la actividad relativa como (actividad observada (pH 7,5)/actividad máx.) * 100%.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13199309 | 2013-12-23 | ||
EP13199309 | 2013-12-23 | ||
PCT/EP2014/078984 WO2015097148A1 (en) | 2013-12-23 | 2014-12-22 | Method for producing oxalate oxidases having activity optimum near physiological ph and use of such recombinant oxalate oxidases in the treatment of oxalate-related diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2694667T3 true ES2694667T3 (es) | 2018-12-26 |
Family
ID=49885050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14819001.0T Active ES2694667T3 (es) | 2013-12-23 | 2014-12-22 | Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato |
Country Status (7)
Country | Link |
---|---|
US (1) | US10266811B2 (es) |
EP (1) | EP3087178B1 (es) |
DK (1) | DK3087178T3 (es) |
ES (1) | ES2694667T3 (es) |
PL (1) | PL3087178T3 (es) |
PT (1) | PT3087178T (es) |
WO (1) | WO2015097148A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6820246B2 (ja) * | 2017-11-30 | 2021-01-27 | 佳人 鳥居 | 免疫活性化剤の製造方法および免疫活性化用飲食品の製造方法 |
CN108935101B (zh) * | 2018-08-13 | 2022-06-07 | 云南省农业科学院花卉研究所 | 一种降低彩纹秋海棠叶片组织培养褐化率的方法 |
CN109793839A (zh) * | 2019-03-13 | 2019-05-24 | 浙江理工大学 | 用于治疗白色念珠菌的三叶青妇科泡腾片及其制备方法 |
CN110432151B (zh) * | 2019-09-11 | 2022-03-25 | 安徽农业大学 | 一种重阳木的组培快繁方法 |
CN110933969A (zh) * | 2019-11-08 | 2020-03-31 | 广西南亚热带农业科学研究所 | 一种提高赤苍藤种子发芽率的方法 |
CN113116764A (zh) * | 2019-12-30 | 2021-07-16 | 四川金铃子生物科技有限公司 | 一种含笑花护肤用品及其制备方法 |
WO2021183818A1 (en) * | 2020-03-12 | 2021-09-16 | University Of Florida Research Foundation, Incorporated | Recombinant oxalate oxidase and uses thereof |
CN111568935B (zh) * | 2020-05-25 | 2022-03-25 | 广西中医药大学 | 赤苍藤提取物在制备抗肿瘤药物中的应用 |
CN111763683B (zh) * | 2020-06-30 | 2022-06-03 | 南京林业大学 | 一种柳杉CfICE1基因及其应用 |
CN112359051B (zh) * | 2020-11-10 | 2023-07-18 | 杭州鑫旺途科技有限公司 | 一种来源于三叶青的苯丙氨酸解氨酶基因ThPAL及其应用 |
CN112772416B (zh) * | 2021-01-28 | 2022-08-12 | 苏州金铁红林业科技有限公司 | 一种小叶桢楠的组织培养育苗方法 |
CN116171863B (zh) * | 2023-03-17 | 2024-02-06 | 江苏省中国科学院植物研究所 | 一种蝴蝶花高效再生的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4455371A (en) | 1982-03-03 | 1984-06-19 | The Ohio State University Research Foundation | Oxalate oxidase composition for assay of oxalate |
CA2610159C (en) * | 2005-06-10 | 2015-03-31 | Altus Pharmaceuticals Inc. | Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
AU2005339139A1 (en) | 2005-12-14 | 2007-06-21 | Oxthera, Inc. | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
EP2504428A4 (en) | 2009-11-25 | 2013-09-25 | Captozyme Llc | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING |
US20110191903A1 (en) * | 2009-12-31 | 2011-08-04 | Pioneer Hi-Bred International, Inc. | Engineering plant resistance to diseases caused by pathogens |
-
2014
- 2014-12-22 US US15/106,914 patent/US10266811B2/en not_active Expired - Fee Related
- 2014-12-22 DK DK14819001.0T patent/DK3087178T3/en active
- 2014-12-22 PT PT14819001T patent/PT3087178T/pt unknown
- 2014-12-22 ES ES14819001.0T patent/ES2694667T3/es active Active
- 2014-12-22 WO PCT/EP2014/078984 patent/WO2015097148A1/en active Application Filing
- 2014-12-22 PL PL14819001T patent/PL3087178T3/pl unknown
- 2014-12-22 EP EP14819001.0A patent/EP3087178B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
US20170037383A1 (en) | 2017-02-09 |
US10266811B2 (en) | 2019-04-23 |
PL3087178T3 (pl) | 2019-03-29 |
EP3087178B1 (en) | 2018-08-08 |
PT3087178T (pt) | 2018-11-21 |
DK3087178T3 (en) | 2018-11-26 |
EP3087178A1 (en) | 2016-11-02 |
WO2015097148A1 (en) | 2015-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2694667T3 (es) | Método para producir oxalato oxidasas que tienen actividad óptica cerca de pH fisiológico y uso de tales oxalato oxidasas recombinantes en el tratamiento de enfermedades relacionadas con oxalato | |
CY1124309T1 (el) | Τροποποιημενα πολυπεπτιδια fgf-21 και χρησεις εξ αυτων | |
CL2020000810A1 (es) | Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas. | |
CL2015002472A1 (es) | Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4. | |
CU20140034A7 (es) | Proteínas de fusión para tratar trastornos metabólicos | |
CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
CY1124761T1 (el) | Ρυθμιστες της δραστικοτητας του συμπληρωματος | |
UY35462A (es) | Formulación de un polipéptido del factor viii. | |
CO2017012454A2 (es) | Secuencias de uricasa adecuadas para el tratamiento de hiperuricemia | |
CL2017002729A1 (es) | Proteína de unión a rgma y su uso | |
NI201500057A (es) | Métodos para reducir riesgos asociados con insuficiencia cardiaca y factores asociados | |
CL2021000129A1 (es) | Apirasas solubilizadas, métodos y usos | |
ECSP20083339A (es) | Proteínas inmunodominantes y fragmentos en esclerosis múltiple | |
AR095076A1 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
PH12016500708A1 (en) | Recombinant glycoproteins and uses thereof | |
MX2019003258A (es) | Composiciones inmunogénicas de consenso sintéticas optimizadas que seleccionan la proteína de activación de fibroblastos como diana. | |
WO2013109190A3 (en) | Cho-gmt recombinant protein expression | |
AR086207A1 (es) | Composiciones y metodos | |
PH12015502037A1 (en) | Activating adiponectin by casein hydrolysate | |
BR112017005573A2 (pt) | enzima solubilizada e usos da mesma | |
MX2018013177A (es) | Proteina de fusion que contiene variante ccl3 y uso de la misma referencia cruzada para aplicaciones relacionadas. | |
BR112017000146A2 (pt) | micro-organismo recombinante do gênero escherichia produzindo ácido quinolínico, e método de produção de ácido quinolínico | |
AR104475A1 (es) | Polipéptidos fgf-21 modificados y sus usos | |
AR099641A1 (es) | OSTEONECTINA (SPARC) COMO BLANCO TERAPÉUTICO PARA EL TRATAMIENTO Y PREVENCIÓN DEL FALLO HEPÁTICO AGUDO, COMPOSICIÓN FARMACEUTICA, CONSTRUCTO GENÉTICO, ARNsi, AGENTE QUE INHIBE LA EXPRESIÓN, USO | |
EA201992746A3 (ru) | Рекомбинантные гликопротеиды и их применения |